ReviewAntibiotics (Basel, Switzerland)2023

Targeting BAM for Novel Therapeutics against Pathogenic Gram-Negative Bacteria.

Claire Overly Cottom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.